Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDES-TNF: Anti-TNF Dose Reduction in Spondylarthropathies
NCT01604629Phase 4Completed
- Sponsor
- Spanish Clinical Pharmacology Society
- Start
- Jul 2012
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab, etanercept, golimumab, infliximab in spondyloarthropathies (SpA), sponsored by Spanish Clinical Pharmacology Society. Started Jul 2012; status: completed.
02
Drugs
03
Conditions
spondyloarthropathies (SpA)
Beyond the preview
Go deeper on NCT01604629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604629.